Views & Analysis The criticality of compliance Remaining compliant is imperative to the life sciences industry, so adhering to regulatory requirements is mandatory.
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
